Synergistic post-transcriptional regulation of the Cystic Fibrosis Transmembrane conductance Regulator (CFTR) by miR-101 and miR-494 specific binding.
about
Targeting MicroRNA Function in Respiratory Diseases: Mini-ReviewMicroRNA Dysregulation in Cystic FibrosisChromatin Dynamics in the Regulation of CFTR ExpressionMicroRNAs: new insights into chronic childhood diseasesNovel insights into miRNA in lung and heart inflammatory diseasesEnvironmental exposures in utero and microRNA.MiR-101 and miR-144 regulate the expression of the CFTR chloride channel in the lungPreferential regulation of stably expressed genes in the human genome suggests a widespread expression buffering role of microRNAsDeciphering miRNA transcription factor feed-forward loops to identify drug repurposing candidates for cystic fibrosis.Gene mutation in microRNA target sites of CFTR gene: a novel pathogenetic mechanism in cystic fibrosis?The innate immune function of airway epithelial cells in inflammatory lung diseaseRole of microRNAs in lung development and pulmonary diseasesRPTOR, a novel target of miR-155, elicits a fibrotic phenotype of cystic fibrosis lung epithelium by upregulating CTGF.Post-transcriptional regulation of cystic fibrosis transmembrane conductance regulator expression and function by microRNAs.Translational repression of SLC26A3 by miR-494 in intestinal epithelial cells.Ion channels/transporters as epigenetic regulators? -a microRNA perspective.Micro-RNAs in inflammatory diseases and as a link between inflammation and cancer.High-throughput profiling for discovery of non-coding RNA biomarkers of lung disease.Peptide Nucleic Acids as miRNA Target Protectors for the Treatment of Cystic Fibrosis.Regulation of mRNA turnover in cystic fibrosis lung disease.Targeting miRNA-based medicines to cystic fibrosis airway epithelial cells using nanotechnologyMicroRNA Expression in Cystic Fibrosis Airway Epithelium.A Peptide Nucleic Acid against MicroRNA miR-145-5p Enhances the Expression of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) in Calu-3 Cells.Non-Coding RNAs in Pediatric Airway Diseases.The expression of Mirc1/Mir17-92 cluster in sputum samples correlates with pulmonary exacerbations in cystic fibrosis patients.Emerging microRNA Therapeutic Approaches for Cystic FibrosisMost recent common ancestor ofTTRVal30Met mutation in Italian population and its potential role in genotype-phenotype correlation
P2860
Q26766476-83B20FB7-3847-4FCB-B729-453489E54BDBQ26799762-F9DFD860-E03D-4945-92E2-89CA1606F17FQ26799886-85AFC802-2DAD-4D27-9DD3-54E94A005787Q26852909-9F15C32F-6A1A-4C45-B7C5-9847CF03C16DQ27026348-F229F9E4-4668-4205-9FD1-A60015D716EEQ34252480-EFC37A63-31D3-4211-8034-10B131C8D54DQ34505995-9D7D8F5F-708D-49B7-BC7B-DE104A6FEDA5Q34529502-2563910B-F2D1-4163-8D4C-C8E97E77925BQ34636525-67FBF419-6696-49E1-B33F-8DC1811084C1Q34653919-38FB2B08-739B-490F-BDE4-484B7328E93AQ36481368-EA055673-98DC-4621-B163-519A28D97E15Q37133793-45E644E5-D358-443C-B97E-F535FB6DE608Q37237979-AA7ED451-DE1A-4E97-B0F8-712965F59B8FQ37297935-8BCFD917-3292-462F-87D9-5B33DDC7D1F6Q37575661-F9D1B69F-BB5A-4082-8D55-D216A718C9DAQ38046769-85D6E13F-80B6-45AC-BBF5-D796A991962CQ38082379-12C1E972-BA30-4E75-8632-83262FE60D85Q38637558-07AB9234-1822-4B7B-B130-573763A47F49Q38683313-8B2E972B-A2B1-42F4-8883-E37F43CF30D8Q39013191-9C735F6E-23D7-4A2E-BCF7-037DC9A0954EQ39076103-3C937133-B86D-4F26-9A7D-4EA1C4F29BC0Q39869793-54B0DF74-69EF-4418-B98D-27EA2695D468Q47246071-06FC2113-579A-4896-B73E-F55A3CB1953CQ47571613-E4D34754-916C-4FD6-9EBA-9DBCAA228A85Q47680467-918B2252-E062-4AC8-829B-974E6D5B8AFFQ57817593-CBD89512-2EA7-453F-8A02-98EF8DBE950FQ58187069-87EA975C-6CDF-4DC0-A199-820092BE7850
P2860
Synergistic post-transcriptional regulation of the Cystic Fibrosis Transmembrane conductance Regulator (CFTR) by miR-101 and miR-494 specific binding.
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Synergistic post-transcription ...... and miR-494 specific binding.
@ast
Synergistic post-transcription ...... and miR-494 specific binding.
@en
Synergistic post-transcription ...... membrane conductance Regulator
@nl
type
label
Synergistic post-transcription ...... and miR-494 specific binding.
@ast
Synergistic post-transcription ...... and miR-494 specific binding.
@en
Synergistic post-transcription ...... membrane conductance Regulator
@nl
prefLabel
Synergistic post-transcription ...... and miR-494 specific binding.
@ast
Synergistic post-transcription ...... and miR-494 specific binding.
@en
Synergistic post-transcription ...... membrane conductance Regulator
@nl
P2093
P2860
P1433
P1476
Synergistic post-transcription ...... and miR-494 specific binding.
@en
P2093
Carlo Dominici
Samantha Cialfi
Serena Quattrucci
P2860
P304
P356
10.1371/JOURNAL.PONE.0026601
P407
P577
2011-10-20T00:00:00Z